A comprehensive suite of guidance, advice and support for delivering quality, safety and efficiency in the use of medicines.
NICE medicines evidence summaries
Summaries of the best available evidence to inform local NHS planning and decision-making, for selected new medicines, or for existing medicines with new indications, and unlicensed or off-label medicines.
More about evidence summaries
Find out about:
- how we help commissioners, budget holders and groups make informed decisions on the introduction of key new medicines
- how we summarise the best available evidence for selected unlicensed or off-label medicines
- how we review the evidence for the clinical effectiveness of medicines.
NICE guidelines provide recommendations for good practice for those individuals and organisations involved in governing, commissioning, prescribing and decision-making about medicines. The outputs have a wide range of audiences across both health and social care environments.Find guidelines
NICE Medicines and prescribing associates
We have a community of associates, who help us to support and promote high quality, safe, cost-effective prescribing and medicines optimisation, within local health economies.
Our associates work with their own organisation and their local health economy to:
- support the adoption of NICE and other high-quality guidance into practice
- improve safety through highlighting issues of medicines safety, risk and ‘never events’
- support the local introduction of new medicines
- develop leadership, facilitation, decision-making and management skills
NICE associates develop and support local networks, identifying local affiliates - key people working locally in prescribing and medicines optimisation - to share and exchange information. Associates also link with the NICE field team and NICE fellows and scholars.
Our associates form a community of practice, supporting each other as an expert group. They share ideas and examples of good practice, as well as receiving information and support from the medicines and prescribing team at NICE
Who is eligible to be an associate?
Health professionals who are NHS employees, NHS contractors (or who are employed by NHS contractors) or employees of non-departmental government bodies are eligible, provided that:
- influencing medicines and prescribing strategy in the NHS is a significant part of their role
- they meet the requirements of the programme relating to declarations of interests, disqualification criteria and the current ‘NICE Medicines and Prescribing Associate Roles and Responsibilities (code of practice)’
- they meet the requirements of the recruitment and assessment programme and display the foundation competencies for NICE medicines and prescribing associates
- they have the support of their employing organisation to become an associate
To become an associate, you need to attend a ‘recruitment and assessment’ course. Our last course ran in December 2015, so the next course is planned for Spring 2017.
If you would like to learn more about our associate programme, please contact the regional technical adviser for your area.
Regional technical advisers
Four regional technical advisers support associates in their roles: one for each NHS England region plus Wales, Northern Ireland or the Channel Islands. Contact them for more information.
- North of England and Northern Ireland: Angela Parkin (email@example.com)
- Midlands and East of England, and Wales: Gill Eddy (firstname.lastname@example.org)
- London: Michelle Liddy (email@example.com)
- South of England and Channel Islands: Zoe Girdis (firstname.lastname@example.org)
Key therapeutic topics
'Medicines optimisation: key therapeutic topics' summarises the evidence-base on topics identified to support medicines optimisation.More about key therapeutic topics
National Prescribing Centre (NPC) legacy website
The National Prescribing Centre (NPC) legacy website has been decommissioned, however you can still access an archived version on the British Library website.
Keep up to date
Sign up for and manage your subscriptions for the medicines awareness service and a range of other newsletters from NICE.Sign up